Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Cash from Financing Activities (2016 - 2025)

InspireMD (NSPR) has 15 years of Cash from Financing Activities data on record, last reported at $52.9 million in Q3 2025.

  • For Q3 2025, Cash from Financing Activities rose 5584.56% year-over-year to $52.9 million; the TTM value through Sep 2025 reached $57.1 million, up 6020.41%, while the annual FY2024 figure was $18.5 million, 50.84% down from the prior year.
  • Cash from Financing Activities reached $52.9 million in Q3 2025 per NSPR's latest filing, up from $2.1 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $52.9 million in Q3 2025 and bottomed at -$965000.0 in Q3 2024.
  • Average Cash from Financing Activities over 4 years is $10.1 million, with a median of $506000.0 recorded in 2025.
  • Peak YoY movement for Cash from Financing Activities: surged 1168833.33% in 2021, then crashed 194.29% in 2022.
  • A 4-year view of Cash from Financing Activities shows it stood at -$35000.0 in 2021, then plummeted by 194.29% to -$103000.0 in 2022, then surged by 1617.48% to $1.6 million in 2024, then surged by 3286.18% to $52.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were $52.9 million in Q3 2025, $2.1 million in Q2 2025, and $506000.0 in Q1 2025.